Brentuximab
Loading...Anti-Brentuximab Products
+ Filter
Loading...- Rabbit Anti-Brentuximab Antibody, PE Conjugated (ABA-018WJ)
-
- Type: Rabbit IgG
- Application: FC
Compare
- Rabbit Anti-Brentuximab Antibody, APC Conjugated (ABA-019WJ)
-
- Type: Rabbit IgG
- Application: FC
Compare
- Rabbit Anti-Brentuximab Antibody, Cy7 Conjugated (ABA-021WJ)
-
- Type: Rabbit IgG
- Application: FC
Compare
- Rabbit Anti-Brentuximab Antibody (ABA-022WJ)
-
- Type: Rabbit IgG
- Application: ELISA, FC, WB
Compare
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).